drugset / Trial / NCT00002455

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

NCT00002455 ↗

Treatment

Summary

RATIONALE: Immunotherapy uses different ways to stimulate the immune system and stop cancer cells from growing. Immunotherapy biological extracts may be useful as adjuvant therapy in treating patients who have had surgery for breast cancer, colon cancer, or melanoma. PURPOSE: Phase III trial to study the effectiveness of Corynebacterium granulosum extract as maintenance immunotherapy following surgery in treating patients with breast cancer, colon cancer, or melanoma.

Timeline

Start
1971-04
Primary completion
—
Completion
—

Publications

  • Background De Carli HO: Immunostimulation and follow-up in long term subclinical cancer. Buenos Aires. Argentina: Centro Oncologico de Excelencia.

Drugs

EvaluationDrugModalityDoseRoute
Subject Corynebacterium granulosum P40 Unknown — Subcutaneous